semaglutide the same as wegovy Weight-loss drug produces 'largest benefit ever seen' for patients with most common form of heart failure, trial finds Novo Nordisk's Wegovy® HD available

Although permanent discontinuation of therapy was recorded in 5.5% of patients, the reasons varied and included elective switches to other incretin-based agents, perceived inadequate efficacy, and patient request

Set aside a medication emergency fund equal to at least one month of treatment cost

Even more pressing for Novo is the China patent office's 2022 ruling that the patent is invalid for reasons related to experimental data availability, which the company has challenged

This is achieved through both central and peripheral channels

The bottom line Oral GLP-1s can be a real option, with real efficacy, for the right person